Email bulletin archive

Archive

December 2020

• 2.5 million people in Africa need urgent hepatitis B treatment
• High hepatitis C cure rate achieved in New York prisons
• London comes together to treat hepatitis C during lockdown
• Experimental treatments for NASH at the Liver Meeting
• Is this your copy of the infohep news bulletin?

November 2020

• News from the 2020 AASLD Liver Meeting
• Which people with chronic liver disease have higher COVID-19 risks?
• Fatty liver greatly increases vulnerability to COVID-19 in obese people
• Minimal monitoring of hepatitis C treatment is safe and effective
• Few countries will meet 2020 target for reducing viral hepatitis deaths
• Can investment in hepatitis C treatment be cost saving?
• Tenofovir alafenamide prevents mother-to-child hepatitis B virus transmission
• Some hepatitis B patients can safely stop antivirals
• NASVAC therapeutic vaccine may lead to functional cure of hepatitis B
• Is this your copy of the infohep news bulletin?

October 2020

• Fatty liver disease affects one in four in Europe
• Experimental treatments for NASH and NAFLD at the Digital International Liver Congress
• Diabetes raises the risk of liver damage in people with HIV
• Fatty liver disease common in people living with HIV and hepatitis B
• Test and treat reduces hepatitis C by 83% in Melbourne gay men with HIV
• Nobel Prize for hepatitis C discovery
• Is this your copy of the infohep news bulletin?

September 2020

• News from the 2020 Digital International Liver Congress
• Predicting liver cancer after hepatitis C is cured
• Immunotherapy for advanced liver cancer
• Liver disease risk in people with HIV
• COVID-19 and liver disease
• Experimental treatments for hepatitis B
• Hepatitis D treatment
• Hepatitis C elimination
• Is this your copy of the infohep news bulletin?

August 2020

• Coming soon: news from the Digital International Liver Congress
• EASL updates guidance on COVID-19 in liver disease patients
• Is hepatitis elimination feasible by 2030?
• COVID-19 slows hepatitis elimination
• Condomless sex sufficient to pass on hepatitis C between men
• Liver cancer risk after hepatitis C cure may be lower in people with HIV
• South Africa: delays in registering direct-acting antivirals for hepatitis C
• Hepatitis testing and treatment in homeless people
• International Liver Congress 2021
• Is this your copy of the infohep news bulletin?

July 2020

• New WHO guidance on preventing mother-to-child transmission of hepatitis B
• Cirrhosis raises the risk of liver injury in COVID-19 patients
• How often does COVID-19 cause liver disorders?
• Hepatitis C drugs may offer a treatment option for COVID-19
• COVID-19 toolkit for patient associations
• World Hepatitis Alliance webinar, 31 July 2020 – Ten years to go: prospects of reaching the 2030 elimination targets in the context of COVID-19
• Hepatitis C doubles the risk of head and neck cancers
• Hepatitis C cure means many liver failure patients have a better chance at transplantation and recovery
• Women suffer less NAFLD but more advanced fibrosis
• Diabetes doubles the risk of advanced liver disease in NAFLD
• Is this your copy of the infohep news bulletin?

June 2020

• International NASH Day
• NASH is fastest-growing reason for a liver transplant in United States
• Bacterial infection of the heart on the rise among people with hepatitis C in United States
• Cameroon study shows hepatitis C treatment is feasible, highly effective in sub-Saharan Africa
• Hepatitis C in England: deaths decline but new infections steady since 2011
• World Hepatitis Day website and campaign materials launched
• Is this your copy of the infohep news bulletin?

May 2020

• COVID-19 in chronic liver disease: advanced cirrhosis greatly raises risk of death
• Controversy: Does non-alcoholic fatty liver disease raise the risk of COVID-19?
• Weight gain after hepatitis C cure is common
• Short-course treatment for recent hepatitis C: some courses may be too short
• Non-alcoholic fatty liver disease affects a quarter of lean people living with HIV
• New estimates highlight need to step up the response to hepatitis D
• International Liver Congress 2020 to take place online
• Is this your copy of the infohep news bulletin?

April 2020

• Liver transplants and COVID-19
• Fatty liver disease may increase risk of severe COVID-19 disease
• New resources on liver disease and COVID-19
• Directly observed treatment for hepatitis C highly effective in people who inject drugs
• Hepatitis C transmission in men who have sex with men
• Is this your copy of the infohep news bulletin?

March 2020

• Liver specialists offer guidance on COVID-19 risks in liver patients
• Are people with chronic liver disease at higher risk of severe COVID-19 symptoms?
• Advice on coronavirus (SARS-CoV-2 / COVID-19) for people with viral hepatitis or liver disease
• All adults ages 18 to 79 should be screened for hepatitis C
• London sets out route map for hepatitis C elimination
• HIV-positive people with fatty liver disease are at high risk for fibrosis
• EASL postpones International Liver Congress 2020 until August
• Epclusa approved for children aged six and over in United States
• Is this your copy of the infohep news bulletin?

February 2020

• Hepatitis C treatment and prevention failing to reach people most affected
• Increase in clean needle and syringe provision essential for hepatitis C elimination
• Half of people who inject drugs in Middle East have hepatitis C
• 90% of injection drug users miss opportunities for HIV or HCV testing
• Hepatitis B treatment suboptimal in people with HIV in Africa
• Medicines Patent Pool and Mylan sign agreement to scale up access to first generic version of hepatitis C treatment glecaprevir/pibrentasvir
• Is this your copy of the infohep news bulletin?

January 2020

• London: hepatitis C elimination depends on testing scale-up
• HepCheck screening programme links 80% to hepatitis C care in 4 European countries
• Peer-led outreach improves uptake of hepatitis C care among homeless and people who use drugs
• Hepatitis C screening among PrEP users could eliminate hepatitis C infections in gay men in UK
• How to check drug interactions with hepatitis C drugs
• Programme provides medical lockers for homeless people to store prescriptions
• Hepatitis C-positive donors a viable option to expand heart donor pool
• Egypt screens 1.6 million school students for hepatitis C
• Is this your copy of the infohep news bulletin?